from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3813c/-

LFCtreatmentdescriptionclass of inhibitor

-1.007

Amikacinug/mL Amikacintranslation

-2.056

Cap5-10ug/mL Capreomycintranslation

-2.938

Rox10-50 ug/mL Roxithromycintranslation

-0.140

SM2-5 ug/mL Streptomycintranslation

-1.737

Tet5-10 ug/mL Tetracyclinetranslation

-0.423

Rif0.2-5ug/mL Rifampicintranscription

-0.034

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.293

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.942

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.450

CPZ10-50 ug/mL Chlorpromazinerespiration

1.457

Clofazimine10-13 ug/mL Clofaziminerespiration

0.654

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.455

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.575

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.127

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.483

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.361

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.439

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.878

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.358

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.654

KCN5-20 ug/mL Potassium cyaniderespiration

1.495

NaN30.2-2 mM Sodium aziderespiration

0.628

Nigericin50 uM Nigericinrespiration

0.775

TRC10-150 ug/mL Triclosanrespiration

-0.073

TRZ10-25 ug/mL Thioridazinerespiration

-0.982

Valinomycin0.5-10 uM Valinomycinrespiration

0.427

ZnSO42 mM ZnSO4respiration

-0.247

menadione6-10 ug/mL Menadionerespiration

0.429

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.121

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.226

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.470

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.033

NRP_1Non-replicating persistence stage 1dosRassociated

0.011

Amp0.2mg/mL AmpicillincellWall

0.192

Cephalexin20-100 ug/mL CephalexincellWall

0.293

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.583

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.420

EMB10-20 ug/mL EthambutolcellWall

0.120

Eta12-40 ug/mL EthionamidecellWall

0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

0.139

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.275

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.501

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.466

BZA0.12 mg/mL BenzamidearomaticAmides

-0.124

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.103

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.440

H2O24 mM hydrogen peroxideDNAdamaging

0.030

Levo10 ug/mL LevofloxacinDNAdamaging

-0.502

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.458

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.147

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.602

UVUV-irradiationDNAdamaging

1.459

ARP41-4 ug/mL Antitubercular compound ARP4?

0.140

Antimycin12.5-50 ug/mL Antimycin A?

0.697

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.252

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.162

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.975

PA8240.2-2 ug/mL PA-824?

1.365

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.677

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.643

Verapamil50 uM Verapamil?

0.168

mercaptoethanol2 mM 2-Mercaptoethanol?

0.955

methoxatin10-20 ug/mL Methoxatin?